While GLP-1RAs and insulin act through different receptors, they share downstream signaling pathways, and by activating these overlapping pathways, GLP-1RAs can aid in restoring insulin signaling that is potentially impaired in patients with type 2 diabetes (Chen et al., 2024). Here, INS is linked to type 2 diabetes mellitus.